期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY LetPub Score 7.9
50 ratings
Rate
Reputation 8.7 Influence 7.0 Speed 9.4 | ||||||||||||||||
期刊簡稱 | AM J OBSTET GYNECOL | ||||||||||||||||
ISSN | 0002-9378 | ||||||||||||||||
E-ISSN | 1097-6868 | ||||||||||||||||
h-index | 203 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 6.90%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.ajog.org/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/AJOG | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Mosby Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1920 | ||||||||||||||||
每年文章數 | 302每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 20.83% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0002-9378%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) 來自Elsevier的數據: Average 5.6 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 17.5 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY] 的評論 | 撰寫評論 |
作者: 蓬莱山欣嘉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-29 14:01:31 評論於 Can we be co-corresponding authors for this journal?(0) 讚! | 蓬莱山欣嘉 |
作者: 江南之云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-06 12:16:08 評論於 Review speed: 1.0 | Submission hit rate: 5.0 Research focus: Multiple pregnancy sharing experiences: submitted on March 13, 2024, under review on March 16, under assessment on March 31, decision made on April 4. The focus is highly clinical, editors are particularly interested in issues that have not been addressed in guidelines or where existing evidence is disputed. The review process is indeed fast, but it also depends on the attitudes of the reviewers. Editors have significant decision-making power, and while all three reviewers found the manuscript interesting and well-written overall, it seems that one of them did not pay enough attention and raised some unimportant issues. The other two mainly focused on data analysis and language issues, which could have been resolved easily, but unfortunately the editor still rejected it(0) 讚! | 江南之云 |
作者: 一只馨逸呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-16 08:25:57 評論於 That is the sheet for signing, there is a template on the official website(0) 讚! | 一只馨逸呀 |
作者: 凌霄洋泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-01 21:33:00 評論於 Why are there so many dates under review?(0) 讚! | 凌霄洋泽 |
作者: 凌霄洋泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-01 15:59:03 評論於 Did you finally accept?(0) 讚! | 凌霄洋泽 |
作者: 般若又易 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-17 10:04:45 評論於 Research focus: Pelvic organ prolapse Experience sharing: September 11 - Submitted September 12 - Being Processed September 13, September 24, October 13, October 26 - Under Review November 2, November 14 - Under Assessment(0) 讚! | 般若又易 |
作者: 无击骊颖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-26 21:39:55 評論於 Hello, may I ask how is the progress going now? Is this "under review" for external review or internal review?(0) 讚! | 无击骊颖 |
作者: 通幽盼松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-20 14:12:40 評論於 10.20 Under Assessment(0) 讚! | 通幽盼松 |
作者: 坂田修齐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-07 19:30:42 評論於 How many reviewers are required to review this magazine before it can be completed?(0) 讚! | 坂田修齐 |
作者: 通幽盼松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-19 16:45:03 評論於 9.16 Submission; 9.20: Being Processed(0) 讚! | 通幽盼松 |
作者: 坂田修齐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-07 20:09:05 評論於 Research focus: Polycystic Ovary Syndrome Experience sharing: Submitted on 8.21, under review since 8.23, entered under review on 9.7(0) 讚! | 坂田修齐 |
作者: 坂田修齐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-30 23:18:47 評論於 How long has your being processed been going on?(0) 讚! | 坂田修齐 |
作者: 琪帆小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-23 13:04:56 評論於 Currently still being processed(0) 讚! | 琪帆小公主 |
作者: 西域俊健 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-04 11:06:55 評論於 Can anyone tell me if the statement of authorship is supposed to be on the official website or can we use our own template? I couldn't find this statement on the official website(0) 讚! | 西域俊健 |
作者: 北风乐青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-15 17:45:15 評論於 Hey, me too... How long did it take for you to go under review in the end?(0) 讚! | 北风乐青 |
作者: 逍遥如寒 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-06 22:47:20 評論於 How long does it take for your manuscript to be processed and receive feedback?(0) 讚! | 逍遥如寒 |
作者: 魔都艳蕙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-20 09:56:18 評論於 Yes, I was being processed on the first day, and then on the second day it changed to under review(0) 讚! | 魔都艳蕙 |
作者: 璃月元思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-31 12:40:08 評論於 Is the status of the submission "under review" after sending the magazine for external review? It has been in the "being processed" status for 2 weeks now(0) 讚! | 璃月元思 |
作者: 魔都艳蕙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-14 10:58:36 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Research emphasis: Cervical cancer Experience sharing: The editing and review speed are very fast. The submission was sent for external review on the second day, and the external review result came back in close to a month. After reading the opinions, I was almost spitting blood. As an old journal in the field of obstetrics and gynecology, the first reviewer had no idea about the progress in this field or the updated guidelines. They did not carefully read the manuscript and directly stated that the research had no clinical significance. However, almost none of the opinions in the review was correct. They even said the recommended treatment in the guidelines was "impractical." The second reviewer had two major comments and several minor ones. The first major comment was to analyze a topic that is still a huge debate in the field, which was completely beyond the scope of my article. If I analyze that, the article could be directly published in a Lancet sub-journal. The second major comment was trivial, simply discussing some limitations in the article. There have been numerous articles using the same analytical methods in the journal recently. Criticizing based on this point was unreasonable. Overall, I am quite disappointed in this journal(0) 讚! | 魔都艳蕙 |
作者: 云碧少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-22 10:26:23 評論於 It's too tragic(0) 讚! | 云碧少爷 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:59:15 評論於 Is the topic of the manuscript within the scope defined by the journal; the academic quality and impact factor of the journal, as well as the acceptance rate; the review and publication cycle of the journal; and the page charges(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:29:45 評論於 Collect and list a wide range of candidate journals; Screen target journals; Decide on the target journal for submission(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:53:40 評論於 What should be noted when choosing a journal?(0) 讚! | 北国博达 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:30:32 評論於 What is the process for selecting articles for publication?(0) 讚! | Oswald Edie |
作者: 水月白云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-18 21:32:14 評論於 Review speed: 1.0 | Submission acceptance rate: 5.0 Research focus: Obstetrics experience sharing: This top journal of obstetrics and gynecology clinical articles is worth reading in every issue, with a very high level. The proportion of articles published by Chinese authors in this journal is very low, so it is very difficult to have one accepted. "In a Lifetime" series~(0) 讚! | 水月白云 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us